Blood marker | Group | N | Baseline | Post-training | 2-way ANOVA/ANCOVA | |
---|---|---|---|---|---|---|
Time effect/effect of baseline | Interaction/post-training difference | |||||
Glucose (mmol/l) | AT | 15 | 6.0 (1.2) | 6.1 (1.4) | p = 0.741 η2 = 0.002 | p = 0.791 η2 = 0.010 |
LL-RT | 16 | 5.6 (0.6) | 5.5 (0.7) | |||
HL-RT | 19 | 5.6 (0.5) | 5.7 (0.5) | |||
Insulin (pmol/l) | AT | 15 | 95 (46) | 98 (58) | p = 0.923 η2 = 0.000 | p = 0.885 η2 = 0.005 |
LL-RT | 16 | 78 (38) | 77 (31) | |||
HL-RT | 19 | 74 (56) | 70 (44) | |||
HOMA2-IR (units) | AT | 15 | 1.82 (0.86) | 1.90 (1.12) | p = 0.965 η2 = 0.000 | p = 0.880 η2 = 0.005 |
LL-RT | 16 | 1.49 (0.71) | 1.46 (0.58) | |||
HL-RT | 19 | 1.40 (1.05) | 1.34 (0.82) | |||
Total cholesterol (mmol/l) | AT | 19 | 3.8 (1.1) | 3.4 (0.9) | p < 0.001 η2 = 0.013 | p = 0.492 η2 = 0.025 |
LL-RT | 19 | 3.2 (0.7) | 3.0 (0.5) | |||
HL-RT | 21 | 3.6 (0.9) | 3.2 (0.5) | |||
HDL (mmol/l) | AT | 19 | 1.2 (0.5) | 1.3 (0.4) | p = 0.961 η2 = 0.000 | p = 0.573 η2 = 0.020 |
LL-RT | 19 | 1.2 (0.4) | 1.2 (0.3) | |||
HL-RT | 21 | 1.2 (0.3) | 1.2 (0.3) | |||
LDL (mmol/l) | AT | 19 | 2.0 (1.0) | 1.6 (0.7) | p < 0.001 η2 = 0.260 | p = 0.499 η2 = 0.025 |
LL-RT | 19 | 1.6 (0.5) | 1.4 (0.4) | |||
HL-RT | 21 | 2.0 (0.7) | 1.5 (0.4) | |||
Triglycerides (mmol/l) | AT | 19 | 1.8 (1.0) | 1.7 (0.9) | p < 0.001 η2 = 0.649 | p = 0.927 η2 = 0.003 |
LL-RT | 19 | 1.3 (0.4) | 1.3 (0.5) | |||
HL-RT | 21 | 1.3 (0.4) | 1.2 (0.4) |